Epstein-Barr virus-positive diffuse large B cell lymphoma, not otherwise specified, carrying a t(19;22)(q13;q11) translocation.
Epstein-Barr virus-positive diffuse large B cell lymphoma, not otherwise specified, carrying a t(19;22)(q13;q11) translocation.
复制标题
Epstein-Barr 病毒阳性弥漫性大 B 细胞淋巴瘤,未另有说明,携带 t(19;22)(q13;q11) 易位。
DOI:
10.1007/s00277-019-03898-2
复制
发表时间:
2020
期刊:
影响因子:
3.5
通讯作者:
Kimura S.
中科院分区:
文献类型:
--
作者:
Yamaguchi K;Kubota Y;Kishimori C;Ohno H;Kidoguchi K;Kizuka-Sano H;Nishioka A;Katsuya H;Ando T;Kimura S.
Dear Editor, Translocation t (19; 22)(q13; q11) is rare in hematological malignancies, and the significance of this chromosomal abnormality is unknown. Here, we report the first case of Epstein-Barr virus (EBV)–positive diffuse large B cell lymphoma (DLBCL), not otherwise specified (NOS), with t (19; 22)(q13; q11).A 74-year-old man, attending a dermatology out-patient clinic for intermittently occurring itchy erythematous papular lesions, was admitted to our hospital because of sore throat, tongue ulcers, and lymph node (LN) swelling. Physical examination showed LN swelling of the cervical, axillary, and inguinal LNs without “B” symptoms. Laboratory examination revealed elevated levels of LDH (350 IU/L) and sIL-2R (1584 U/mL). 18F-fluorodeoxyglucose positron emission tomography/computed tomography showed hypermetabolic lesions in the oropharynx and multiple LNs, as well as several skin lesions. Histopathological examination of a biopsy specimen from the right axillary LN showed diffuse proliferation of lymphoma cells with large nuclei and centroblastic features (Fig. 1a). Immunohistochemistry revealed that the neoplastic cells were positive for CD20, CD79a, CD30, and MUM1, and negative for CD10 and BCL6, suggesting a non-germinal center B cell origin. Both EBV-encoded small RNA in situ hybridization and EBV latent membrane protein were positive,